introduction
What is blood-derived stem cell therapy?
Stem cell therapy has moved well beyond the laboratory. Hematopoietic stem cells (HSCs) reside in your bone marrow and can be mobilised into the bloodstream for collection. Because these cells come from your own body, they carry no rejection risk and no compatibility concerns associated with donor treatments.
View Skin Clinic holds a government-designated Advanced Regenerative Medicine facility licence, operating fully within Korea’s Ministry of Health and Welfare regulatory framework. Blood-derived stem cell therapy Korea patients trust is now available at our Seoul clinic.
MINIMALLY INVASIVE
How blood stem cells are collected
The collection process is straightforward and minimally invasive. Depending on your treatment plan, stem cells are harvested using one of two methods.
Peripheral blood draw with mobilisation : A short course of G-CSF stimulates hematopoietic stem cells (HSCs) to move from the bone marrow into the peripheral bloodstream. Once the cell count reaches the optimal level—typically within four to five days—the cells are collected through a standard blood draw. The procedure requires no surgery, sedation, or hospital stay.
Apheresis : For protocols requiring a higher cell yield, blood is drawn from a vein, passed through a separator that isolates stem cells, and the remaining blood is returned to the body in the same session. The procedure takes two to four hours and is performed in our certified medical environment.
Quality assured
Laboratory processing
After collection, your sample is transferred directly to our certified clean-room processing suite. Raw blood contains a mix of cell types, and therapeutic application requires careful concentration and quality verification.
Centrifugation & Separation
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Flow Cytometry
Cell count and viability confirmed. Preparations below minimum therapeutic threshold are not released.
Sterility Testing
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Cryopreservation (if indicated)
Optional storage in liquid nitrogen for staged protocols. Viability maintained above 90% under standard conditions.
Regulatory Note Korea’s Ministry of Health and Welfare requires that facilities handling autologous stem cell preparations hold a designated Advanced Regenerative Medicine facility licence. View holds all required certifications and welcomes requests to review documentation.
CLINICAL APPLICATIONS
What can blood-derived stem cells treat?
HSCs and the growth factors they secrete have demonstrated utility across several clinical areas. At View Skin Clinic, blood-derived stem cell therapy is offered for the following indications.
01
Systemic Health Restoration
Intravenous infusion of autologous haematopoietic stem cells is used as a supportive intervention for patients seeking to address systemic decline associated with ageing, prolonged stress, or general health deterioration. By replenishing circulating progenitor cells and modulating the body’s regenerative environment, the treatment aims to support overall vitality, physical resilience, and long-term wellbeing. Conducted under strict clinical monitoring and subject to individual eligibility assessment.
02
Skin Rejuvenation
Paracrine signaling from stem cells stimulates local fibroblast activity, supporting collagen synthesis and improving skin texture, tone, and fine line appearance. Results develop gradually over four to twelve weeks post-treatment.
03
Scalp & Hair
Growth factors such as VEGF and HGF, present in stem cell preparations, have been associated with improved follicle microcirculation, making them a complementary option for patients experiencing diffuse hair thinning.
04
Systemic Anti-Aging
As part of a broader preventive medicine programme, IV stem cell infusion aims to support cellular repair mechanisms that naturally decline with age. It is intended as a supportive intervention, not a cure for age-related diseases.
For fat-derived alternatives, see our Adipose Stem Cell Therapy page. For bone marrow concentrate protocols, visit our BMAC page.
Patient Journey
What to expect during treatment
Blood-derived stem cell therapy at View follows a structured six-step protocol. Each stage is medically supervised and designed around your individual health profile.
total visits
4-6
appointments
treatment window
2-3 wks
collection to admin
downtime
Minimal
same-day return
effect
4-12 wks
post-administration
1
Consultation & eligibility screening
In-clinic · 60 min
A View physician reviews your medical history and treatment goals to determine the most appropriate protocol, whether for skin rejuvenation, scalp health, immune support, or IV anti-aging therapy.
Medical History Review
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Baseline Blood Panel
CBC, liver/kidney function, infection markers, HSC mobilisation suitability confirmed.
Photographic Baseline
Standardised photography of the treatment area for outcome tracking.
Protocol Design
Personalised treatment plan drafted including collection method and administration route.
Note Active autoimmune disease, recent malignancy, or active systemic infection may affect eligibility. Your physician will advise during this session.
2
Stem cell mobilisation
In-clinic · 60 min
A short course of G-CSF injections encourages hematopoietic stem cells to migrate from the bone marrow into the bloodstream. The injections can be self-administered at home or administered by a nurse at the clinic.
Injection Schedule
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Expected Side Effects
Mild bone ache, low-grade fever, or fatigue typically resolves within 1–2 days of completing the course.
Apheresis Patients Mobilisation may be adjusted or omitted depending on your target cell yield. Your physician will confirm during step 1.
3
Cell collection
In-clinic · 30 min – 4 hrs
Collection takes place at View Skin Clinic under clinical supervision. Two methods are available depending on your protocol and required cell yield.
Peripheral Blood Draw
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Apheresis
Blood drawn, stem cells separated, remaining blood returned in the same session. 2–4 hours.
Comfort Both methods are well-tolerated. You may eat and drink normally beforehand. Most patients return to normal activity the same day.
4
Clean-room laboratory processing
Lab · 1–2 hours
A View physician reviews your medical history and treatment goals to determine the most suitable treatment protocol for skin rejuvenation, scalp health, immune support, or IV anti-aging therapy.
Centrifugation
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Flow Cytometry
CBC, liver/kidney function, infection markers, HSC mobilisation suitability confirmed.
Sterility Testing
Full panel per Ministry of Food and Drug Safety (MFDS) standards.
Cryopreservation
Optional storage in liquid nitrogen for staged protocols. Viability above 90%.
5
Administration
In-clinic · 60 min
Once your preparation passes quality verification, administration is scheduled. Delivery method is determined by your target indication and confirmed during consultation.
Intradermal Injection
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
IV Infusion
For systemic anti-aging and immune support. Slow drip over 60–90 min with continuous monitoring.
Photographic Baseline
Standardised photography of the treatment area for outcome tracking.
Protocol Design
Personalised treatment plan drafted including collection method and administration route.
After Your Session Mild redness or swelling at the site is expected and subsides within 24–72 hours. Avoid strenuous exercise and direct sun for 48 hours.
6
Follow-up & outcome review
In-clinic · 60 min
A View physician reviews your full health history and treatment goals to determine the most suitable protocol for skin rejuvenation, scalp care, immune support, or IV anti-aging therapy.
Photographic Comparison
Mononuclear cell fraction containing HSCs and progenitor cells is isolated from plasma and red cells.
Outcome Questionnaire
Structured patient-reported outcome form completed at each follow-up.
Repeat Blood Panel
Standardised photography of the treatment area for outcome tracking.
Next Session Planning
Personalised treatment plan drafted including collection method and administration route.
Note Active autoimmune disease, recent malignancy, or active systemic infection may affect eligibility. Your physician will advise during this session.
EVIDENCE – BASED
Safety & results
Autologous therapy uses your own cells, eliminating the primary risks associated with donor stem cell treatments, including immune rejection, graft-versus-host disease, and the transmission of infectious diseases.
Reported adverse effects in autologous HSC applications are generally mild and transient. Serious adverse events are rare. As with any medical procedure, individual response varies, and View Skin Clinic does not make outcome guarantees.
Patients considering blood-derived stem cell therapy Korea practitioners offer should always verify that their provider holds the appropriate government designation. View holds all required certifications and welcomes requests to review documentation.
common side effects
- Injection-site redness or swelling typically resolves within 24–72 hours.
- Temporary fatigue following collection
- Mild flu-like symptoms during G-CSF mobilisation phase
- Mild arm fatigue or light-headedness during apheresis (resolves immediately)
Clinical Note Published peer-reviewed data on autologous stem cell applications for aesthetic and anti-aging indications is growing but remains an evolving evidence base. Your physician will present relevant literature and realistic expectations during your consultation.
why view
Why choose View Skin Clinic
01
Government Licensed
Designated as an Advanced Regenerative Medicine facility by Korea’s Ministry of Health and Welfare, View Plastic Surgery is one of a limited number of clinics authorised to perform this therapy.
02
Certified Clean-Room Lab
On-site processing meeting Ministry of Food and Drug Safety sterility and viability standards. Your sample never leaves our facility.
03
Autologous — Zero Rejection
Your own cells. No donor risk, no graft-versus-host response, no compatibility testing required.
FAQ
Frequently asked questions
Is this the same as a stem cell IV drip I've seen advertised online?
No. Many marketed “stem cell drips” contain exosomes or conditioned media, not live autologous cells. View uses cells isolated directly from your blood under certified laboratory conditions — a regulated medical procedure, not a wellness supplement.
How many sessions will I need?
Most protocols involve 1–3 sessions spaced 4–8 weeks apart, followed by a maintenance review at 3 months.
Is the G-CSF mobilisation injection safe?
G-CSF (filgrastim) has been used in haematology for over 30 years with a well-characterised safety profile. Side effects are typically mild and short-lived.
How is this different from PRP?
PRP isolates platelets and growth factors but does not concentrate stem cells. The two therapies are complementary and sometimes used together.
Can I combine this with other treatments at View?
Yes, in many cases. Combination protocols are designed case-by-case during your consultation, with sequencing and safety taken into account.
Ready to explore your options?
Book a consultation at View Skin Clinic in Seoul. Our physicians will assess your suitability and design a protocol matched to your goals — with no obligation to proceed.